Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 10, 2023

SELL
$76.01 - $86.7 $152 - $173
-2 Reduced 2.04%
96 $7,000
Q1 2023

May 10, 2023

SELL
$77.31 - $88.08 $695 - $792
-9 Reduced 8.41%
98 $8,000
Q4 2022

Feb 01, 2023

BUY
$62.32 - $89.47 $249 - $357
4 Added 3.88%
107 $9,000
Q3 2022

Nov 03, 2022

BUY
$59.54 - $68.01 $893 - $1,020
15 Added 17.05%
103 $6,000
Q2 2022

Aug 09, 2022

BUY
$57.72 - $65.01 $404 - $455
7 Added 8.64%
88 $5,000
Q1 2022

Apr 22, 2022

BUY
$57.92 - $72.58 $1,969 - $2,467
34 Added 72.34%
81 $5,000
Q1 2021

May 12, 2021

BUY
$60.0 - $68.46 $840 - $958
14 Added 42.42%
47 $3,000
Q4 2020

Feb 12, 2021

SELL
$56.65 - $64.55 $16,428 - $18,719
-290 Reduced 89.78%
33 $2,000
Q3 2020

Nov 05, 2020

BUY
$62.1 - $78.08 $6,210 - $7,808
100 Added 44.84%
323 $20,000
Q4 2019

May 19, 2020

BUY
$61.62 - $67.78 $13,741 - $15,114
223 New
223 $14,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Disciplined Investments, LLC Portfolio

Follow Disciplined Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Disciplined Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Disciplined Investments, LLC with notifications on news.